A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis
Condition: Moderate Pain in Knee Osteoarthritis · Severe Pain in Knee Osteoarthritis · Sponsor: Shandong Suncadia Medicine Co., Ltd.
About this study
Primary Objective: To explore the effectiveness of different doses of HRS-2129 in the treatment of patients with moderate to severe pain in knee osteoarthritis. Secondary Objectives: To evaluate the safety of different doses of HRS-2129 for the treatment of patients with moderate to severe pain in knee osteoarthritis; To evaluate the population pharmacokinetic profile of HRS-2129 in patients with knee osteoarthritis.
This description comes directly from the study's public registry record.
Talk to the study team
Zhuang Nie · +86-0518-82342973 · zhuang.nie@hengrui.com
Always discuss trial participation with your own doctor first.
Locations (1)
| Drum Tower Hospital affiliated to Nanjing University School of Medicine | Nanjing, Jiangsu, China | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07351968